ScaiVision® performs best-in-class at sample class prediction!

VACANCY: Data Analyst in Biomarker Discovery

We are expanding our research portfolio in multiple disease indications and are looking to strengthe

Read more

Scailyte and Lexogen create a joint biomarker discovery workflow for precision medicine companies

Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution

Read more

Scailyte Quarterly Update, June 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Scailyte announces Michael Brenner, of Harvard Medical School, as an advisor to its Board of Directors

Artificial Intelligence (AI)-driven biomarker discovery innovator Scailyte announced today that Mich

Read more

Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV2 infection

Read more

Scailyte Quarterly Update, April 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Scailyte and Geninus announce a strategic partnership to develop a predictive assay for immune-checkpoint inhibitors in Non-Small Cell Lung Cancer patients

Artificial Intelligence (AI)-driven biomarker discovery innovator Scailyte and the global single-cel

Read more

Scailyte and Volv Global announce strategic partnership to accelerate rare disease patient diagnosis

Two Artificial Intelligence (AI)-driven biomarker discovery companies Scailyte and Volv Global today

Read more